55 related articles for article (PubMed ID: 15863898)
1. In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine.
Chen Y; Liu L; Laille E; Kumar G; Surapaneni S
Cancer Chemother Pharmacol; 2010 Apr; 65(5):995-1000. PubMed ID: 20119716
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants.
Polasek TM; Miners JO
Br J Clin Pharmacol; 2008 Jan; 65(1):87-97. PubMed ID: 17662092
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes.
Yeo KR; Yeo WW
Br J Clin Pharmacol; 2001 May; 51(5):461-70. PubMed ID: 11422004
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of the In Vitro Inhibitory Effects of Thelephoric Acid and SKF-525A on Human Cytochrome P450 Activity.
Song M; Do H; Kwon OK; Yang EJ; Bae JS; Jeong TC; Song KS; Lee S
Biomol Ther (Seoul); 2014 Feb; 22(2):155-60. PubMed ID: 24753822
[TBL] [Abstract][Full Text] [Related]
5.
Varghese A; Savai J; Pandita N; Gaud R
Toxicol Rep; 2015; 2():806-816. PubMed ID: 28962416
[No Abstract] [Full Text] [Related]
6. In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.
Fowler S; Zhang H
AAPS J; 2008 Jun; 10(2):410-24. PubMed ID: 18686042
[TBL] [Abstract][Full Text] [Related]
7. EIDD-1931 Treatment Tweaks CYP3A4 and CYP2C8 in Arthritic Rats to Expedite Drug Interaction: Implication in Oral Therapy of Molnupiravir.
Bhardwaj M; Kour D; Rai G; Bhattacharya S; Manhas D; Vij B; Kumar A; Mukherjee D; Ahmed Z; Gandhi SG; Nandi U
ACS Omega; 2024 Mar; 9(12):13982-13993. PubMed ID: 38559969
[TBL] [Abstract][Full Text] [Related]
8. The Cytochrome P450 (CYP) 2C8*3 Variant (rs11572080) is Associated with Improved Asthma Symptom Control in Children and Altered Lipid Mediator Production and Inflammatory Response in Human Bronchial Epithelial Cells.
Almestica-Roberts M; Nguyen ND; Sun L; Serna SN; Rapp E; Burrell-Gerbers KL; Memon TA; Stone BL; Nkoy FL; Lamb JG; Deering-Rice CE; Rower JE; Reilly CA
Drug Metab Dispos; 2024 May; ():. PubMed ID: 38772712
[TBL] [Abstract][Full Text] [Related]
9. BDDCS applied to over 900 drugs.
Benet LZ; Broccatelli F; Oprea TI
AAPS J; 2011 Dec; 13(4):519-47. PubMed ID: 21818695
[TBL] [Abstract][Full Text] [Related]
10. Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism.
Liu YN; Chen J; Wang J; Li Q; Hu GX; Cai JP; Lin G; Xu RA
Arch Toxicol; 2023 Aug; 97(8):2133-2142. PubMed ID: 37209178
[TBL] [Abstract][Full Text] [Related]
11. Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes.
Xia Z; Wang M; Zou S; Chen R
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):211-6. PubMed ID: 22161476
[TBL] [Abstract][Full Text] [Related]
12. The management of hypertensive emergencies in children after stem cell transplantation.
Horn DG; Trame MN; Hempel G
Int J Clin Pharm; 2011 Apr; 33(2):165-76. PubMed ID: 21394568
[TBL] [Abstract][Full Text] [Related]
13. Coprescription of tamoxifen and medications that inhibit CYP2D6.
Sideras K; Ingle JN; Ames MM; Loprinzi CL; Mrazek DP; Black JL; Weinshilboum RM; Hawse JR; Spelsberg TC; Goetz MP
J Clin Oncol; 2010 Jun; 28(16):2768-76. PubMed ID: 20439629
[TBL] [Abstract][Full Text] [Related]
14. Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.
Curran MP; Robinson DM; Keating GM
Drugs; 2006; 66(13):1755-82. PubMed ID: 16978041
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes.
Nakamura K; Ariyoshi N; Iwatsubo T; Fukunaga Y; Higuchi S; Itoh K; Shimada N; Nagashima K; Yokoi T; Yamamoto K; Horiuchi R; Kamataki T
Biol Pharm Bull; 2005 May; 28(5):882-5. PubMed ID: 15863898
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Jeong HU; Lee HS
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
19. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.
Khojasteh SC; Prabhu S; Kenny JR; Halladay JS; Lu AY
Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):1-16. PubMed ID: 21336516
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
